Hereditary Hemorrhagic Telangiectasia (HHT) Center
Agency: Health Resources and Services Administration
Assistance Listings: 93.110 -- Special Projects of Regional and National Significance
Description
The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.
Eligibility
Eligible applicants
Miscellaneous
- Unrestricted
Government
- State governments
Additional information
Grantor contact information
Description
nwilliams1@hrsa.gov
Documents
No documents are currently available.
Link to additional information
--
Forecasted
Estimated Post Date:
May 1, 2026
Estimated Application Due Date:
June 1, 2026
Estimated Due Date Description:
Not available
Estimated Award Date:
August 2, 2026
Estimated Project Start Date:
September 1, 2026
Fiscal Year:
2026
Award
$2,900,000
Program Funding
1
Expected awards
$--
Award Minimum
$2,900,000
Award Maximum
Funding opportunity number:
HRSA-26-092
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Health
Category Explanation:
History
Version:
3
Forecast posted date:
March 16, 2026
Archive date:
July 1, 2026
